Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by considering the role heavy metals such as lead, mercury, and cadmium can play in Alzheimer's Disease.

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by discussing the multifactorial influences that contribute to Alzheimer's Disease progression.

More than 800 people from over 75 countries came together virtually on 3rd June 2025 for the eleventh edition of the RELX SDG Inspiration Day: "The Future of Philanthropy: Stepping up for the SDGs" The annual online event brings together together business, academia, NGOs and government to explore pressing issues and inspire action on the United Nations Sustainable Development Goals (SDGs). Explore highlights from the day including inspiring keynotes from Ban Ki-moon, 8th Secretary General of the United Nations, Sir Lenny Henry and Sarah, Duchess of York.

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by exploring a novel area of research exploring the link between vascular disease and Alzheimer's Disease.

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by providing an overview of the cholinergic hypothesis of Alzheimer's Disease and potential innovations in cholinergic therapies.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by discussing the understudied impacts of the gut microbiome and chronic inflammation that may contribute to neurodegeneration.
Elsevier,

Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Advances, 2025, pp 3-15

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by discussing the roles of Tau, glial, and amyloid (A) in Alzheimer's Disease development.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by discussing the role of genetic variants found to affect cholinergic and noncholinergic neurotransmission.
This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by examining novel medications and drug delivery systems to advance the treatment of Alzheimer's Disease.
Elsevier,

Tryptamine Microbiota-Deregulated Aminoacyl-tRNA Biosynthesis: A Conceptual Evolution of the Role of Microbiota Tryptamine in Human Diseases, 2024, pp 253-267

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by highlighting the data demonstrating the role tryptamine plays in Alzheimer's Disease.

Pages